Gray Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$255K Hold
617
0.1% 110
2024
Q3
$312K Sell
617
-4
-0.6% -$1.94K 0.12% 96
2024
Q2
$303K Hold
621
0.13% 92
2024
Q1
$335K Buy
621
+2
+0.3% +$1.09K 0.15% 87
2023
Q4
$344K Hold
619
0.17% 81
2023
Q3
$271K Hold
619
0.14% 93
2023
Q2
$311K Buy
619
+20
+3% +$9.58K 0.16% 88
2023
Q1
$300K Buy
599
+40
+7% +$19.1K 0.16% 92
2022
Q4
$228K Buy
+559
New +$217K 0.13% 102
2022
Q2
Sell
-480
Closed -$263K 118
2022
Q1
$263K Hold
480
0.14% 96
2021
Q4
$316K Buy
480
+15
+3% +$9.42K 0.16% 88
2021
Q3
$289K Hold
465
0.16% 88
2021
Q2
$294K Hold
465
0.17% 87
2021
Q1
$228K Buy
465
+20
+4% +$10K 0.14% 101
2020
Q4
$222K Buy
+445
New +$199K 0.15% 99

Other funds holding IDXX

Gray Wealth Management's IDXX Position: Q4 2024 in Review

Gray Wealth Management held its Idexx Laboratories (IDXX) position steady in Q4 2024 at 617 shares worth $255K. The position accounts for 0.1% of the portfolio, ranked #110.

Gray Wealth Management first reported a position in IDXX in Q4 2020 and has held it in 15 quarters since. The position peaked at $344K in Q4 2023. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Gray Wealth Management held 617 shares of Idexx Laboratories worth $255K as of Q4 2024.
  • Gray Wealth Management left its Idexx Laboratories share count unchanged in Q4 2024.
  • Idexx Laboratories made up 0.1% of Gray Wealth Management's portfolio in Q4 2024, its #110 holding.
  • Gray Wealth Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 15 quarters since.
  • Gray Wealth Management's Idexx Laboratories position peaked at $344K in Q4 2023.
  • 1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Gray Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.